The securities fraud trial for pharmaceutical executive Martin Shkreli, now in its fifth week, is grinding to its conclusion.
July 24, 2017 at 06:23 PM
1 minute read
The securities fraud trial for pharmaceutical executive Martin Shkreli, now in its fifth week, is grinding to its conclusion.
On Monday, prosecutors from the Eastern District U.S. Attorney’s Office called their final witness, FBI agent Michael Braconi, and said they could rest as early as Tuesday.
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
